Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed mitogen-activated protein kinase kinase kinase 5, which mediates various stress signals including oxidative stress. The catalytic activity of ASK1 is tightly controlled by oligomerization and binding of several cofactors. Among these cofactors, thioredoxin stands out as the most important ASK1 inhibitor, but only the reduced form of thioredoxin inhibits ASK1 by direct binding to its N-terminal domain. In addition, oxidation-driven thioredoxin dissociation is the key event in oxidative stress-mediated ASK1 activation. However, the structural mechanism of ASK1 regulation by thioredoxin remains unknown. Here, we report the characterization of the ASK1 domain responsible for thioredoxin binding and its complex using NMR spectroscopy and chemical cross-linking, thus providing the molecular basis for ASK1: thioredoxin complex dissociation under oxidative stress conditions. Our data reveal that the N-terminal domain of ASK1 adopts a fold resembling the thioredoxin structure while retaining substantial conformational plasticity at the thioredoxin-binding interface. Although oxidative stress induces relatively moderate structural changes in thioredoxin, the formation of intramolecular disulfide bridges leads to a considerable conformational rearrangement of the thioredoxin-binding interface on ASK1. Moreover, the cysteine residue at position 250 of ASK1 is the key element of this molecular switch. Finally, our results show that the redox-active site of thioredoxin is directly involved in ASK1 binding that is modulated by oxidative stress, thereby identifying a key target for the structure-based drug design.

Department of Cell Biology Faculty of Science Charles University Prague Czech Republic

Department of Physical and Macromolecular Chemistry Faculty of Science Charles University Prague Czech Republic

Department of Structural Biology of Signaling Proteins Division BIOCEV Institute of Physiology of the Czech Academy of Sciences Vestec Czech Republic

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K & Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.

Shiizaki S, Naguro I & Ichijo H (2013) Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling. Adv Biol Regul 53, 135-144.

Kawarazaki Y, Ichijo H & Naguro I (2014) Apoptosis signal-regulating kinase 1 as a therapeutic target. Expert Opin Ther Targets 18, 1-14.

Nishida T, Hattori K & Watanabe K (2017) The regulatory and signaling mechanisms of the ASK family. Adv Biol Regul 66, 2-22.

Ryuno H, Naguro I & Kamiyama M (2017) ASK family and cancer. Adv Biol Regul 66, 72-84.

Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K & Ichijo H (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2, 389-395.

Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K & Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J 17, 2596-2606.

Zhang L, Chen J & Fu H (1999) Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 96, 8511-8515.

Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J, Inoue J & Ichijo H (2005) Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J Biol Chem 280, 37033-37040.

Tobiume K, Saitoh M & Ichijo H (2002) Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 191, 95-104.

Cheng Z, Zhang J, Ballou DP & Williams CH Jr (2011) Reactivity of thioredoxin as a protein thiol-disulfide oxidoreductase. Chem Rev 111, 5768-5783.

Liu Y & Min W (2002) Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90, 1259-1266.

Fujino G, Noguchi T, Matsuzawa A, Yamauchi S, Saitoh M, Takeda K & Ichijo H (2007) Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol Cell Biol 27, 8152-8163.

Cockrell LM, Puckett MC, Goldman EH, Khuri FR & Fu H (2010) Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome. Oncogene 29, 822-830.

Liu H, Nishitoh H, Ichijo H & Kyriakis JM (2000) Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 20, 2198-2208.

Goldman EH, Chen L & Fu H (2004) Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation. J Biol Chem 279, 10442-10449.

Weijman JF, Kumar A, Jamieson SA, King CM, Caradoc-Davies TT, Ledgerwood EC, Murphy JM & Mace PD (2017) Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1. Proc Natl Acad Sci USA 114, E2096-E2105.

Kylarova S, Kosek D, Petrvalska O, Psenakova K, Man P, Vecer J, Herman P, Obsilova V & Obsil T (2016) Cysteine residues mediate high-affinity binding of thioredoxin to ASK1. FEBS J 283, 3821-3838.

Kosek D, Kylarova S, Psenakova K, Rezabkova L, Herman P, Vecer J, Obsilova V & Obsil T (2014) Biophysical and structural characterization of the thioredoxin-binding domain of protein kinase ASK1 and its interaction with reduced thioredoxin. J Biol Chem 289, 24463-24474.

Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J & Min W (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94, 1483-1491.

Nadeau PJ, Charette SJ & Landry J (2009) REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell 20, 3628-3637.

Renshaw PS, Veverka V, Kelly G, Frenkiel TA, Williamson RA, Gordon SV, Hewinson RG & Carr MD (2004) Sequence-specific assignment and secondary structure determination of the 195-residue complex formed by the Mycobacterium tuberculosis proteins CFP-10 and ESAT-6. J Biomol NMR 30, 225-226.

Veverka V, Lennie G, Crabbe T, Bird I, Taylor RJ & Carr MD (2006) NMR assignment of the mTOR domain responsible for rapamycin binding. J Biomol NMR 36 (Suppl 1), 3.

Shen Y, Delaglio F, Cornilescu G & Bax A (2009) TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR 44, 213-223.

Arora A, Abildgaard F, Bushweller JH & Tamm LK (2001) Structure of outer membrane protein A transmembrane domain by NMR spectroscopy. Nat Struct Biol 8, 334-338.

Shen Y, Lange O, Delaglio F, Rossi P, Aramini JM, Liu G, Eletsky A, Wu Y, Singarapu KK, Lemak A et al. (2008) Consistent blind protein structure generation from NMR chemical shift data. Proc Natl Acad Sci USA 105, 4685-4690.

Receveur-Brechot V & Durand D (2012) How random are intrinsically disordered proteins? A small angle scattering perspective. Curr Protein Pept Sci 13, 55-75.

Forman-Kay JD, Clore GM, Stahl SJ & Gronenborn AM (1992) 1H and 15N resonance assignments and secondary structure of the human thioredoxin C62A, C69A, C73A mutant. J Biomol NMR 2, 431-445.

Weichsel A, Gasdaska JR, Powis G & Montfort WR (1996) Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 4, 735-751.

Dominguez C, Boelens R & Bonvin AM (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125, 1731-1737.

Nadeau PJ, Charette SJ, Toledano MB & Landry J (2007) Disulfide bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol Biol Cell 18, 3903-3913.

Hashemy SI & Holmgren A (2008) Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283, 21890-21898.

Kaufmann KW, Lemmon GH, Deluca SL, Sheehan JH & Meiler J (2010) Practically useful: what the Rosetta protein modeling suite can do for you. Biochemistry 49, 2987-2998.

Qin J, Clore GM & Gronenborn AM (1994) The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. Structure 2, 503-522.

Zauhar RJ, Colbert CL, Morgan RS & Welsh WJ (2000) Evidence for a strong sulfur-aromatic interaction derived from crystallographic data. Biopolymers 53, 233-248.

Dunker AK, Cortese MS, Romero P, Iakoucheva LM & Uversky VN (2005) Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272, 5129-5148.

Dancheck B, Nairn AC & Peti W (2008) Detailed structural characterization of unbound protein phosphatase 1 inhibitors. Biochemistry 47, 12346-12356.

Lee SR, Yang KS, Kwon J, Lee C, Jeong W & Rhee SG (2002) Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277, 20336-20342.

Watson JA, Rumsby MG & Wolowacz RG (1999) Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: thioredoxin inhibits protein kinase C-mediated phosphorylation of histone. Biochem J 343 (Pt 2), 301-305.

Funato Y, Michiue T, Asashima M & Miki H (2006) The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol 8, 501-508.

Niesen FH, Berglund H & Vedadi M (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2, 2212-2221.

Addis PW, Hall CJ, Bruton S, Veverka V, Wilkinson IC, Muskett FW, Renshaw PS, Prosser CE, Carrington B, Lawson AD et al. (2014) Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation. J Biol Chem 289, 7200-7210.

Jeng MF, Campbell AP, Begley T, Holmgren A, Case DA, Wright PE & Dyson HJ (1994) High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin. Structure 2, 853-868.

Williamson MP (2013) Using chemical shift perturbation to characterise ligand binding. Prog Nucl Magn Reson Spectrosc 73, 1-16.

Bradley P, Misura KM & Baker D (2005) Toward high-resolution de novo structure prediction for small proteins. Science 309, 1868-1871.

Raman S, Lange OF, Rossi P, Tyka M, Wang X, Aramini J, Liu G, Ramelot TA, Eletsky A, Szyperski T et al. (2010) NMR structure determination for larger proteins using backbone-only data. Science 327, 1014-1018.

Herrmann T, Guntert P & Wuthrich K (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319, 209-227.

Harjes E, Harjes S, Wohlgemuth S, Muller KH, Krieger E, Herrmann C & Bayer P (2006) GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1. Structure 14, 881-888.

Roessle MW, Klaering R, Ristau U, Robrahn B, Jahn D, Gehrmann T, Konarev P, Round A, Fiedler S, Hermes C et al. (2007) Upgrade of the small-angle X-ray scattering beamline X33 at the European Molecular Biology Laboratory, Hamburg. J Appl Crystallogr 40, S190-S194.

Svergun DI (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Crystallogr 25, 495-503.

Franke D & Svergun DI (2009) DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J Appl Crystallogr 42, 342-346.

Volkov VV & Svergun DI (2003) Uniqueness of ab initio shape determination in small-angle scattering. J Appl Crystallogr 36, 860-864.

Kozin MB & Svergun DI (2001) Automated matching of high- and low-resolution structural models. J Appl Crystallogr 34, 33-41.

Young MM, Tang N, Hempel JC, Oshiro CM, Taylor EW, Kuntz ID, Gibson BW & Dollinger G (2000) High throughput protein fold identification by using experimental constraints derived from intramolecular cross-links and mass spectrometry. Proc Natl Acad Sci USA 97, 5802-5806.

Kopecka M, Kosek D, Kukacka Z, Rezabkova L, Man P, Novak P, Obsil T & Obsilova V (2014) Role of the EF-hand-like motif in the 14-3-3 protein-mediated activation of yeast neutral trehalase Nth1. J Biol Chem 289, 13948-13961.

Svergun D, Barberato C & Koch MHJ (1995) CRYSOL - a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J Appl Crystallogr 28, 768-773.

Krissinel E & Henrick K (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D 60, 2256-2268.

The cryo-EM structure of ASK1 reveals an asymmetric architecture allosterically modulated by TRX1

Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions

The 14-3-3 Proteins as Important Allosteric Regulators of Protein Kinases